Cannabis and Cannabinoids: Pharmacology and Rationale for Clinical Use

Publisher： Karger

E-ISSN： 1661-4127|6|3|12-15

ISSN： 1661-4119

Source： Forschende Komplementärmedizin / Research in Complementary Medicine, Vol.6, Iss.3, 2004-11, pp. : 12-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Medical education on cannabis and cannabinoids: Perspectives, challenges, and opportunities

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 6, 2015-06 ,pp. : 548-550

John Wiley & Sons Inc

Access to resources Recommend Favorite

Rationale for the use of rifaximin in inflammatory bowel diseases based on clinical trial results

By Lorenzetti Roberto   Prantera Cosimo  

Clinical Investigation, Vol. 3, Iss. 12, 2013-12 ,pp. : 1187-1193

Future Science

Access to resources Recommend Favorite

Clinical Pharmacology

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 115, Iss. s1, 2014-07 ,pp. : 54-91

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacology and clinical use of recombinant activated factor seven in neurosciences

By  

Neurocritical Care, Vol. 6, Iss. 2, 2007-04 ,pp. : 149-157

Humana Press, Inc

Access to resources Recommend Favorite

Medical cannabis vs. synthetic cannabinoids: What does the future hold?

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 97, Iss. 6, 2015-06 ,pp. : 568-570

John Wiley & Sons Inc

Access to resources Recommend Favorite